Skip to content

The inhibitory effect of NVIF2025-01 intake on fructose absorption

The inhibitory effect of NVIF2025-01 intake on fructose absorption - The inhibitory effect of NVIF2025-01 intake on fructose absorption

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000059121
Enrollment
20
Registered
2025-09-23
Start date
2025-09-24
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Test drink, containing NVIF2025-01 (a single time intake) Test drink, containing NVIF2025-01 (a single time intake) -&gt

Sponsors

Nagase Viita Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Male and female employees of Nagase Vita Co., Ltd. aged 18 to 65 who have been employed for over one year. 2) Those who do not work in shifts for the convenience of subject management. 3) Those who do not smoke or consume excessive alcohol. 4) Those who are not pregnant, may not be pregnant, or are not breastfeeding during the trial period. 5) Those who have no history of conditions or medications that could affect the trial. 6) Those who have never been diagnosed with impaired glucose tolerance or dyslipidemia. 7) Those whose liver function and blood glucose test values from their most recent health checkup are within normal ranges. 8) BMI (Body Mass Index) is included between 18.5 to less than 30. 9) Those who do not experience regular abdominal discomfort. 10) Those who have no allergies to the provided foods. 11) Those who are comfortable with consuming sweet beverages. 12) Those who are considered suitable for participation by the investigator.

Exclusion criteria

Exclusion criteria: Those who are judged inappropriate for the study by the investigator.

Design outcomes

Primary

MeasureTime frame
Postprandial blood fructose dynamics

Countries

Japan

Contacts

Public ContactYu Oka

Nagase Viita Co., Ltd. Research, Technology & Value Creation Division, Product Value Creation Department

yu.oka@nagase.co.jp0862763141

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Sep 19, 2026